Recombinant Saccharomyces cerevisiae Putative uncharacterized protein YPL283W-A (YPL283W-A)

What are the basic characteristics of the YPL283W-A protein?

YPL283W-A is a putative uncharacterized protein from Saccharomyces cerevisiae. The mature protein spans amino acids 18-191, with the gene YPL283W-B having a transcript length of 483 nucleotides and classified as protein-coding . The protein was identified through gene-trapping, microarray-based expression analysis, and genome-wide homology searching in the S. cerevisiae S288c strain . While its specific function remains unknown, it represents one of the many proteins in the yeast proteome that have yet to be fully characterized.

What expression systems can be used to produce recombinant YPL283W-A?

• Prokaryotic systems: E. coli remains the most common, offering high yield and relatively straightforward purification when using affinity tags like His-tag.

• Eukaryotic systems:

  • Homologous expression in S. cerevisiae itself

  • Pichia pastoris for higher yield of secreted proteins

  • Insect cells for complex eukaryotic modifications

The choice depends on research goals - E. coli is suitable for structural studies requiring high protein quantities, while homologous expression in yeast might preserve native folding and modifications critical for functional studies .

How can I verify successful expression of recombinant YPL283W-A?

Verification of successful expression typically employs:

• Western blotting: Using anti-His antibodies (if His-tagged) or developing specific antibodies against YPL283W-A.

• SDS-PAGE: To visualize the protein band at the expected molecular weight.

• Mass spectrometry: For definitive identification and characterization.

• Functional assays: Though challenging with uncharacterized proteins, co-expression with potential interacting partners could reveal activity.

Expression verification was demonstrated in similar studies where immunoblot analysis confirmed expression of recombinant proteins in yeast lysates using specific antibodies .

What experimental design would be most appropriate for determining the function of YPL283W-A?

A comprehensive experimental design to determine YPL283W-A function should include:

Phase 1: Computational Analysis

• Conduct sequence homology searches against characterized proteins

• Perform structural prediction to identify potential functional domains

• Analyze protein-protein interaction networks using databases

Phase 2: Expression Profiling

• Monitor expression under various stress conditions (temperature, nutrient limitation, oxidative stress)

• Conduct RNA-seq to identify co-expressed genes under sulfur starvation and other conditions

Phase 3: Functional Analysis

• Generate knockout/knockdown strains using CRISPR-Cas9

• Perform phenotypic screening under various growth conditions

• Conduct protein localization studies using GFP fusion constructs

Phase 4: Interaction Studies

• Perform yeast two-hybrid screening to identify protein interaction partners

• Conduct co-immunoprecipitation followed by mass spectrometry

• Examine potential RNA interactions using RNAct data

This multi-phased approach follows established principles of experimental design, ensuring variables are properly controlled while systematically exploring functional characteristics .

How should I approach RNA-protein interaction studies for YPL283W-A?

RNA-protein interaction studies for YPL283W-A require a systematic approach:

• In silico prediction: Utilize computational tools such as RNAct that have already identified potential RNA interactions with YPL283W-A . According to available data, YPL283W-A shows prediction scores below the significance threshold for most tested RNA interactions, suggesting it may not be a strong RNA-binding protein.

• In vitro validation:

  • RNA electrophoretic mobility shift assays (REMSA)

  • RNA immunoprecipitation (RIP) followed by sequencing

  • CLIP-seq for precise mapping of binding sites

• Functional validation:

  • Mutagenesis of predicted RNA-binding residues

  • Expression analysis of potential target RNAs in YPL283W-A mutants

  • Reporter assays to assess impact on RNA stability or translation

The RNAct database shows interaction predictions with several proteins including YOR381W-A, HHF1, and others, though with relatively low prediction scores (around 2.8) . This suggests that while RNA interaction is possible, it may not be the primary function of YPL283W-A.

How can transcriptomic analysis help characterize YPL283W-A function?

Transcriptomic analysis provides powerful insights into potential functions of uncharacterized proteins like YPL283W-A:

Methodological Approach:

• Differential expression analysis:

  • Generate YPL283W-A deletion and overexpression strains

  • Perform RNA-seq under multiple conditions (e.g., normal growth, stress conditions)

  • Apply statistical analysis using packages like DESeq2

• Co-expression network analysis:

  • Identify genes with similar expression patterns to YPL283W-A

  • Construct gene networks using algorithms such as WGCNA

  • Determine potential pathways based on enriched functional categories

• Integration with other datasets:

  • Compare results with profiles of known mutations in related genes

  • Analyze previously published datasets such as the response to sulfur starvation

  • Examine correlations with metabolic changes

Mining transcriptomic data using machine learning algorithms (as demonstrated for ethanol production genes) could reveal if YPL283W-A is associated with specific cellular responses or metabolic processes .

What approaches can be used to study potential roles of YPL283W-A in immune response when expressed in recombinant yeast vaccines?

While YPL283W-A's native function remains unknown, recombinant S. cerevisiae has been used successfully as a vaccine vehicle. To study potential immunological roles:

• Construct generation and validation:

  • Generate recombinant S. cerevisiae expressing YPL283W-A under a constitutive promoter like TEF2

  • Confirm expression via immunoblot analysis

  • Verify heat-killing process maintains protein integrity

• In vitro immune response assessment:

  • Expose dendritic cells to recombinant yeast-YPL283W-A

  • Measure dendritic cell maturation markers (CD80, CD86, MHC II)

  • Assess cross-presentation to CD8+ T cells using peptide-MHC tetramers

• In vivo immunogenicity studies:

  • Vaccinate appropriate mouse models

  • Measure CD4+ and CD8+ T-cell responses via ELISpot or intracellular cytokine staining

  • Assess memory T-cell formation using CCR7 and other markers

• Comparative analysis:

  • Compare immune responses to yeast-YPL283W-A versus control yeast

  • Determine if YPL283W-A contains immunogenic epitopes

  • Evaluate if YPL283W-A enhances or modulates the adjuvant properties of yeast

This approach follows established methodologies for evaluating recombinant yeast vaccines, where yeast serves both as an expression system and adjuvant .

How can regulatory networks involving YPL283W-A be identified and analyzed?

To elucidate regulatory networks involving YPL283W-A:

• Transcription factor analysis:

  • Use YEASTRACT database to identify transcription factors that potentially regulate YPL283W-A

  • Conduct ChIP-seq experiments to validate binding in vivo

  • Perform reporter assays with YPL283W-A promoter constructs

• Regulator cluster analysis:

  • Apply tools like RegulatorDB to identify regulators and target genes

  • Analyze the regulatory effect of identified transcription factors on YPL283W-A

  • Examine the impact of transcription factor mutants on YPL283W-A expression

• Network reconstruction:

  • Generate a directed graph of regulatory interactions

  • Identify feedback loops and feed-forward motifs

  • Determine if YPL283W-A is part of specific regulatory modules

Studies in S. cerevisiae have successfully used transcription factor analysis and regulator cluster diagrams to reveal regulatory relationships. For example, research identified several key transcription factors (YGR067C, HAP4, NRG2, TUP1, TOS8, MSN4, and PDC2) that regulate genes important for ethanol production . Similar approaches could uncover whether YPL283W-A is regulated by these or other transcription factors.

What purification strategies are most effective for recombinant His-tagged YPL283W-A expressed in E. coli?

For His-tagged YPL283W-A purification from E. coli:

• Lysis optimization:

  • For cytoplasmic expression: Use sonication or homogenization in buffer containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, and protease inhibitors

  • For potential inclusion bodies: Include 8M urea or 6M guanidine-HCl for denaturation

• IMAC purification:

  • Use Ni-NTA or Co-TALON affinity chromatography

  • Apply stepwise imidazole gradient (10-250 mM) for optimal elution

  • Monitor purification efficiency via SDS-PAGE at each step

• Secondary purification:

  • Size exclusion chromatography to remove aggregates

  • Ion exchange chromatography for charged contaminants

• Quality assessment:

  • Western blot using anti-His antibodies

  • Mass spectrometry for identity confirmation

  • Dynamic light scattering for homogeneity analysis

This approach is based on standard purification methods for His-tagged proteins and should allow isolation of YPL283W-A in a form suitable for further functional and structural studies.

How can I design experiments to identify potential interacting partners of YPL283W-A?

To identify interacting partners of YPL283W-A:

• Affinity purification-mass spectrometry (AP-MS):

  • Express tagged YPL283W-A in yeast (TAP-tag or FLAG-tag)

  • Perform gentle lysis to maintain protein complexes

  • Capture complexes using appropriate affinity matrix

  • Identify co-purifying proteins by mass spectrometry

  • Validate interactions using reciprocal pull-downs

• Yeast two-hybrid screening:

  • Construct bait plasmid with YPL283W-A fused to DNA-binding domain

  • Screen against prey library of S. cerevisiae proteins

  • Validate positive interactions by retesting and co-immunoprecipitation

• Proximity-based labeling:

  • Fuse YPL283W-A to BioID or APEX2

  • Express in yeast to allow proximity-dependent biotinylation

  • Purify biotinylated proteins and identify by mass spectrometry

• Co-expression analysis:

  • Mine transcriptomic datasets to identify co-regulated genes

  • Use algorithms to predict functional associations based on co-expression patterns

These approaches provide complementary data on different types of interactions (stable, transient, physical, functional) and should be used in combination for a comprehensive interactome analysis.

What are common challenges when working with uncharacterized proteins like YPL283W-A and how can they be addressed?

Working with uncharacterized proteins presents several challenges:

• Low expression levels:

  • Optimize codon usage for expression host

  • Test multiple promoters and fusion partners

  • Consider inducible expression systems with tight regulation

• Protein instability:

  • Add stabilizing fusion partners (MBP, GST, SUMO)

  • Screen buffer conditions using differential scanning fluorimetry

  • Include appropriate protease inhibitors during purification

• Lack of functional assays:

  • Develop phenotypic screens for knockout/overexpression strains

  • Use comparative genomics to identify potential functions

  • Apply untargeted metabolomics or proteomics to identify perturbations

• Difficult subcellular localization:

  • Create GFP fusions at both N- and C-termini

  • Verify functionality of fusion proteins

  • Use fractionation followed by western blotting as confirmatory approach

• Limited reagents:

  • Develop specific antibodies against peptide regions

  • Create epitope-tagged versions for detection

  • Establish reporter systems for indirect functional assessment

These approaches are based on standard methodologies for working with challenging proteins and can help overcome the typical obstacles encountered with uncharacterized proteins like YPL283W-A.

How can contradictory experimental results regarding YPL283W-A function be reconciled and analyzed?

When faced with contradictory results regarding protein function:

• Systematic evaluation of experimental conditions:

  • Catalog all variables between contradictory experiments

  • Test if specific media components, growth phases, or stress conditions affect results

  • Determine if strain background differences explain contradictions

• Methodological validation:

  • Cross-validate using orthogonal techniques

  • Perform positive and negative controls in parallel

  • Assess technical variability through replication

• Data integration approach:

  • Apply Bayesian statistical methods to weigh evidence from different experiments

  • Create a consensus model that explains most observations

  • Identify edge cases and special conditions that might explain outlier results

• Collaboration strategy:

  • Organize ring trials between laboratories reporting contradictory findings

  • Standardize protocols and reagents

  • Perform blinded analyses to minimize bias

• Computational reconciliation:

  • Use machine learning to identify patterns in seemingly contradictory datasets

  • Apply systems biology approaches to place contradictory results in broader context